Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.620
-0.040 (-2.41%)
Oct 30, 2026, 4:00 PM EDT
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
189.25M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| Ascend Wellness Holdings | 693.48M |
| TerrAscend | 374.77M |
| Organigram Global | 309.18M |
| Auxly Cannabis Group | 165.57M |
| Medexus Pharmaceuticals | 146.70M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 79.87M |
Cardiol Therapeutics News
- 5 weeks ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial - TheFly
- 5 weeks ago - Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PRNewsWire
- 6 weeks ago - Cardiol Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Cardiol Therapeutics receives over $7M in proceeds from warrant exercise - TheFly
- 6 weeks ago - Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds - PRNewsWire
- 6 weeks ago - Cardiol Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 weeks ago - Cardiol Therapeutics files $150M preliminary base shelf prospectus - TheFly